![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1403473
¼¼°è ÀǾàǰ ĸ½¶ Áß·®¼±º°±â ½ÃÀå ¿¹Ãø(-2030³â) : ÀÚµ¿È ¼öÁغ°, ¿ë·®º°, ÅëÇÕ ¼öÁغ°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®Pharmaceutical Capsule Checkweigher Market Forecasts to 2030 - Global Analysis By Automation Level, Capacity, Integration Level, Technology, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°è ÀǾàǰ ĸ½¶ Áß·®¼±º°±â ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
ƯÈ÷ ÀǾàǰ ĸ½¶¿ëÀ¸·Î ¸¸µé¾îÁø Áß·®¼±º°±â ½ÃÀå ºÎ¹®Àº ÀǾàǰ ĸ½¶ Áß·®¼±º°±â ½ÃÀåÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. ÀÌ À¯ÇüÀÇ ÀåºñÀÇ »ý»ê, À¯Åë ¹× »ç¿ë¿¡ ÁýÁßÇÕ´Ï´Ù. °¢ ĸ½¶ÀÇ ¹«°Ô°¡ µ¿ÀÏÇÔÀ» º¸ÀåÇÏ°í ¾ö°ÝÇÑ ±ÔÁ¤À» ÁؼöÇϰí Á¦Ç°ÀÇ Ç°ÁúÀ» À¯ÁöÇÔÀ¸·Î½áÀÌ Á¤¹Ð Àåºñ´Â ÀǾàǰ Á¦Á¶¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀǾàǰ Á¦Á¶ °øÁ¤ÀÇ Áß¿äÇÑ ¿ä¼ÒÀÎ °Ë·®±â´Â º¹¿ë·® ºÒÀÏÄ¡¸¦ ¾ø¾Ö°í ȯÀÚÀÇ ¾ÈÀü°ú È¿´ÉÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
ÀǾàǰ Á¦Á¶¾÷ü´Â ¾ö°ÝÇÑ Ç°Áú °ü¸® ¿ä±¸ »çÇ×À» À¯ÁöÇϰí Á¦Á¶ ºñ¿ëÀ» Àý°¨Çϸç È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ ÃÖ¼±À» ´ÙÇϰí ÀÖ½À´Ï´Ù. ÀǾàǰ ĸ½¶ÀÌ ÁöÁ¤µÈ Áß·® ¸Å°³º¯¼ö¸¦ ÃæÁ·ÇÏ´ÂÁö È®ÀÎÇϱâ À§ÇØ, Áß·®¼±º°±â´Â °è·® °øÁ¤¿¡¼ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú Á¤¹Ðµµ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, È¿À²ÀûÀ̰í Á¤È®ÇÏ°Ô ´ë»ó¹°À» ÃøÁ¤ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÚµ¿ üũ¿þÀÌÀú´Â »ý»ê °øÁ¤ÀÇ ÇÕ¸®È, ¹Ì½ºÀ²ÀÇ Àú°¨, ÀüüÀûÀÎ ¾÷¹« È¿À²ÀÇ Çâ»ó¿¡ µµ¿òÀÌ µË´Ï´Ù.
Á¦¾àȸ»ç´Â ƯÈ÷ ÀÚ±ÝÀÌ Á¦ÇÑµÈ ¼Ò±Ô¸ð ±â¾÷À̳ª ¼ºÀå ÁßÀÎ ±â¾÷¿¡ ÀÖ¾î¼ Áß·®¼±º°±âÀÇ Ã·´Ü ±â¼ú°ú Á¤¹Ðµµ¿¡ µû¸¥ °í¾×ÀÇ Ãʱ⠺ñ¿ëÀÌ Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±¸¸Å, ¹èÄ¡ ¹× ÇöÀç »ý»ê ¶óÀο¡ ÅëÇÕÇÏ´Â µ¥ µå´Â ºñ¿ëÀº ǰÁú °ü¸® ÀýÂ÷¸¦ °³¼±ÇÏ·Á´Â ±â¾÷¿¡°Ô À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àüü ÀÚ±Ý ºÎ´ãÀ» Áõ°¡½Ã۱â À§ÇØ ÅõÀÚ´Â Ãëµæ»Ó¸¸ ¾Æ´Ï¶ó °ËÁõ, À¯Áö º¸¼ö ¹× ±³À° ºñ¿ë±îÁö È®ÀåµË´Ï´Ù.
ÀǾàǰ¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§Çؼ´Â Á¦Á¶ ´É·ÂÀÇ Çâ»óÀÌ ÇÊ¿äÇϸç, À̸¦ À§Çؼ´Â È¿°úÀûÀÌ°í ½Å·Ú¼º ³ôÀº ǰÁú °ü¸® ÀýÂ÷°¡ Áß¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óȲ¿¡¼ Á¡°Ë¿ë ºÐµ¿°è´Â ÀǾàǰ ĸ½¶ÀÇ Á¤È®ÇÑ Áß·®À» º¸ÁõÇϰí ÀǾàǰÀÇ Á¾ÇÕÀûÀΠǰÁú º¸Áõ¿¡ µµ¿òÀÌ µÇ±â À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ °Ç° °ü¸® ½Ã½ºÅÛ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Á¦¾à ȸ»ç°¡ »ý»ê·®À» Áõ°¡½ÃŰ´Â µ¿¾È ¿ë·® Á¤È®¼ºÀ» À¯ÁöÇÏ°í °ú¼Ò Åõ¿© ¹× °ú´Ù Åõ¿© ¹®Á¦¸¦ ÇÇÇϱâ À§ÇØ Áß·®¼±º°±â »ç¿ëÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù.
¹«´Ü ¾×¼¼½º ¶Ç´Â À¯ÇØÇÑ ÇàÀ§´Â ¼Ò·® °è·®±â¿¡ ÀÇÇØ »ý¼ºµÈ µ¥ÀÌÅ͸¦ ³ë¸± ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ¿¡´Â ÀǾàǰ ó¹æ ¹× Á¦Á¶ ÀýÂ÷¿¡ ´ëÇÑ Áß¿äÇÑ Á¤º¸°¡ Æ÷Ç﵃ ¼ö ÀÖ½À´Ï´Ù. ÁöÀû Àç»êÀÇ µµ³, À§Á¶, ÀǾàǰ Á¦Á¶ Áß´ÜÀ» ¹æÁöÇϱâ À§Çؼ´Â ÀÌ·¯ÇÑ Á¤º¸ÀÇ ÇÁ¶óÀ̹ö½Ã, Á¤È®¼º ¹× Á¢±Ù¼ºÀ» È®º¸ÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±â¹Ð µ¥ÀÌÅ͸¦ º¸È£Çϱâ À§ÇØ °è·®±â Á¦Á¶¾÷ü¿Í »ç¿ëÀÚ´Â ¾ÏÈ£È, ¾×¼¼½º Á¦ÇÑ, ºó¹øÇÑ º¸¾È °¨»ç µî °·ÂÇÑ »çÀ̹ö º¸¾È Á¶Ä¡¸¦ ÃëÇØ¾ß ÇÕ´Ï´Ù.
ÀǾàǰ »ç¾÷Àº »ý»ê °¨¼Ó, ¼¼°è °ø±Þ¸Á È¥¶õ, Çʼöǰ ¿ì¼± ¼øÀ§ ÁöÁ¤ µîÀÇ ¿µÇâÀ» ¹Þ¾ÒÀ¸¸ç, ÀÌµé ¸ðµÎ°¡ ¼Ò·® °è·® Àåºñ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿ªº´ÀÇ À¯ÇàÀ» ¹Þ¾Æ ÀǾàǰÀÇ Á¦Á¶°¡ ±ØÀûÀ¸·Î Áõ°¡ÇßÀ½¿¡µµ ºÒ±¸Çϰí, ÇʼöÀûÀÎ Ä¡·á¿¡ ÁÖ¾ÈÀÌ ³õ¿©Áø °á°ú »ý»êÀÇ ¿ì¼±¼øÀ§°¡ º¯ÈÇß½À´Ï´Ù. ºÒÈ®½Ç¼ºÀ» °ü¸®Çϱâ À§ÇØ ¸î¸î Á¦Á¶¾÷ü°¡ °Ë·®±â¿Í °°Àº »õ·Î¿î ±â°èÀÇ ±¸¸Å¸¦ ´ÊÃ߰ųª Àç°ËÅäÇß½À´Ï´Ù. ¶ô´Ù¿îÀ̳ª ¿©Çà Á¦Çѵµ üũ °è·® ±â±âÀÇ ¼³Ä¡³ª À¯Áöº¸¼ö¸¦ °ï¶õÇÏ°Ô Çß½À´Ï´Ù.
ÀÚµ¿ üĿ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ÀÌÀ¯´Â ¿î¿µ È¿À²¼ºÀ» ³ôÀ̰í ÀΰǺñ¸¦ ÁÙÀ̰í ÀǾàǰ ĸ½¶ Á¦Á¶ °øÁ¤¿¡¼ Á¤È®ÇÏ°í ½Å¼ÓÇÏ¸ç ½Ç½Ã°£ Áß·® ÃøÁ¤À» Á¦°øÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ ÀÚµ¿ °è·®±â´Â Á¤È®¼º°ú Á¤È®¼ºÀÌ Áß¿äÇÑ ÀǾàǰ »ç¾÷¿¡¼ ´ë·® »ý»ê¿¡ ǰÁú °ü¸®¸¦ ¿øÈ°ÇÏ°Ô ÅëÇÕÇÏ´Â Á¤±³ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù.
µ¶¸³Çü üĿ´Â »ó´çÇÑ º¯È°¡ ÇÊ¿ä ¾øÀ¸¸ç, ÇöÀç ÀǾàǰ Á¦Á¶ ¶óÀο¡ ½±°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â µ¶¸³Çü ¼Ö·ç¼ÇÀ» Á¦°øÇϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ Àüü °ø±Þ¸ÁÀ» À籸¼ºÇÏÁö ¾Ê°í È¿°úÀûÀΠǰÁú °ü¸® ¼Ö·ç¼ÇÀ» ¿ä±¸ÇÏ´Â Á¦¾à ȸ»ç´Â ÀÌ·¯ÇÑ À¯¿¬¼º¿¡ ¸Å·ÂÀ» ´À³¥ ¼ö ÀÖ½À´Ï´Ù. ÀǾàǰ ĸ½¶ÀÇ Á¤È®ÇÑ Áß·® ÃøÁ¤Àº µ¶¸³Çü °è·®±â¿¡ ÀÇÇØ Á¦°øµÇ¸ç ¹ýÀû ¿ä±¸ »çÇ× Áؼö ¹× Á¦Ç° ǰÁú À¯Áö¸¦ º¸ÀåÇÕ´Ï´Ù.
Á¦¾à Á¦Á¶¾÷üµéÀÌ »ý»ê È¿À²¼º Çâ»ó, ¹ý±Ô Áؼö º¸Àå, ÃÖ°í ¼öÁØÀÇ Á¦Ç° ǰÁú À¯Áö¸¦ ¼±È£ÇÏ´Â ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼´Â °è·®±â »ç¿ëÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ½ÃÀåÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. °Ô´Ù°¡, üũ °è·® ±â¼úÀÌ Á¦°øÇÏ´Â ±â´ÉÀº Á¦Çü¿¡¼ Á¤È®¼º°ú Á¤È®¼ºÀÇ Á߿伺 Áõ°¡¸¦ µû¸¨´Ï´Ù. ±ÔÁ¦ ±â°üÀº Á¤È®ÇÑ º¹¿ë·® ÃøÁ¤°ú ±¹Á¦ ǰÁú ±âÁØ Áؼö¸¦ Áß¿ä½ÃÇϱ⠶§¹®¿¡ Áß·®¼±º°±â´Â ÀǾàǰ Á¦Á¶ ¾÷¹«¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù.
ºÏ¹Ì´Â À¯¸®ÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ FDA(Food and Drug Administration: ½ÄǰÀǾàǰ±¹)°¡ ºÎ°úÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦È¯°æ¿¡¼´Â ¾ö°ÝÇÑ Ç°Áú°ü¸® ÀýÂ÷°¡ ¿ä±¸µÇ¹Ç·Î ÀǾàǰ Á¦Á¶¾÷¹«¿¡¼ üũ¿þÀÌÀúÀÇ Á߿伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ºÏ¹Ì Á¦¾à ±â¾÷Àº ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Áß½ÃÇϰí Á¤È®ÇÑ º¹¿ë·®À» ÃßÁ¤ÇÒ Çʿ伺 ¶§¹®¿¡ ±ÔÁ¦ Áؼö¸¦ À¯ÁöÇϱâ À§ÇØ °è·®±â°¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
2023³â 7¿ù ÇØ´ç °úÇÐÀÇ ¼¼°è ¸®´õÀÎ Thermofisher Scientific(ÀÌÇÏ Thermofisher)Àº ¿À´Ã ½ÂÀÎµÈ Ä¡·á¹ý ¹× Ä¡·á¹ý¿¡ ´ëÇÑ ±ÔÁ¦ µî±ÞÀÇ ½ÇÁ¦ ÀÓ»ó Áõ°Å¸¦ Á¦°øÇÏ´Â ¼±µÎ ÁÖÀÚ ÇÁ·Î¹ÙÀÌ´õÀÎ CorEvitas, LLC»ç¸¦ ÀμöÇÏ´Â ÃÖÁ¾ °è¾àÀ» ü°áÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.
13.1 OCS Checkweighers GmbH
13.2 Thermo Fisher Scientific Inc.
13.3 Anritsu Corporation
13.4 Dover Corporation
13.5 Shanghai Bilon Instrument Co., Ltd
13.6 Mettler-Toledo International Inc.
13.7 Wipotec-OCS GmbH
13.8 Bizerba GmbH & Co. KG
13.9 Sejong Pharmatech
JHS 24.01.23According to Stratistics MRC, the Global Pharmaceutical Capsule Checkweigher Market is growing at a CAGR of 6.7% during the forecast period. The market segment for check-weighing equipment made especially for pharmaceutical capsules is known as the Pharmaceutical Capsule Checkweigher Market. It is concentrated on the production, distribution, and use of this type of equipment. By ensuring that each capsule weighs identically, ensuring that strict regulations are adhered to, and preserving product quality, this precision equipment is essential to the manufacturing of pharmaceuticals. Checkweighers, a crucial component of the pharmaceutical production process, help to eliminate dosage discrepancies, improving patient safety and efficacy.
Manufacturers of pharmaceuticals strive intensively to maintain strict quality control requirements, lower production costs, and increase efficiency. To ensure that pharmaceutical capsules satisfy specified weight parameters, checkweighers provide real-time monitoring and precision in the weighing process, which is crucial to attaining these objectives. Additionally, because they can measure objects efficiently and accurately, automated check weighers help to streamline production processes, reduce mistake rates, and improve overall operational efficiency.
Pharmaceutical producers have a hurdle because of the high upfront expenses associated with check weighing equipment's sophisticated technology and precision, particularly for smaller or growing businesses with limited funding. The cost of purchasing, placing in position, and integrating checkweighers into current production lines can be a barrier for businesses seeking to improve their quality control procedures. To further increase the entire financial commitment, the investment expands beyond acquisition to cover costs for validation, maintenance, and training.
Increased manufacturing capacity is required to meet the growing global demand for medicines, which emphasizes the importance of effective and dependable quality control procedures. In this context, check weighers are essential as they ensure the exact weight of pharmaceutical capsules, which helps to ensure the total quality assurance of drugs. Additionally, the use of check weighers is crucial to preserving dosage accuracy and avoiding problems with under or overdosing as pharmaceutical businesses increase their production volumes to meet the growing demands of the healthcare system.
Unauthorized access or harmful activity may target the data produced by checkweighing equipment, which may contain critical information regarding pharmaceutical formulations and production procedures. It is crucial to ensure the privacy, accuracy, and accessibility of this information in order to prevent intellectual property theft, counterfeiting, and interruptions in the production of pharmaceuticals. To protect sensitive data, checkweigher manufacturers and users must set strong cybersecurity measures in place, such as encryption, access limits, and frequent security audits.
The pharmaceutical business was impacted by production slowdowns, global supply chain disruptions, and the prioritization of necessities, which all had an impact on the demand for checkweighing equipment. Despite the fact that pharmaceutical manufacturing increased dramatically in response to the epidemic, priorities in production shifted as a result of the primary focus on essential treatments. To manage uncertainty, a few manufacturers experienced delays or reconsidered their purchases of new machinery, such as checkweighers. Lockdowns and travel restrictions also made it difficult to install and maintain checkweighing equipment.
The market for automatic checkweighers is anticipated to grow at a rapid pace throughout the projected period because of its capacity to improve operational effectiveness, reduce labor costs, and offer accurate, fast, and real-time weight measurements in the pharmaceutical capsule production process. Additionally, automatic checkweighers provide a sophisticated way to smoothly integrate quality control into high-volume manufacturing in the pharmaceutical business, where accuracy and precision are critical.
Because it provides a stand-alone solution that can be readily integrated into current pharmaceutical production lines without requiring significant changes, the Standalone Checkweighers segment is anticipated to grow at a rapid pace throughout the projected period. Moreover, pharmaceutical businesses looking for effective quality control solutions without having to reorganize their entire supply chain may find this flexibility appealing. Accurate weight measurements for pharmaceutical capsules are provided by standalone checkweighers, ensuring adherence to legal requirements and preserving product quality.
The usage of checkweighers is significantly increasing in the Asia-Pacific area, where pharmaceutical manufacturers prioritize improving production efficiency, guaranteeing regulatory compliance, and maintaining the highest standards of product quality. This region held the largest share of the market. Furthermore, the capabilities provided by check weighing technology are in line with the growing emphasis on accuracy and precision in dosage formulations. Checkweighers are an essential part of pharmaceutical manufacturing operations because regulatory bodies emphasize the importance of precise dosage measurements and compliance with international quality standards.
North America region is experiencing lucrative growth. Strict regulatory environments, such as those imposed by the Food and Drug Administration (FDA) in the United States, require stringent quality control procedures, which increases the significance of checkweighers in pharmaceutical production operations. Moreover, checkweighing equipment is becoming more widely used by pharmaceutical businesses in North America to maintain regulatory compliance, with a focus on patient safety and the necessity for precise dosage estimates.
Some of the key players in Pharmaceutical Capsule Checkweigher market include: OCS Checkweighers GmbH, Thermo Fisher Scientific Inc., Anritsu Corporation, Dover Corporation, Shanghai Bilon Instrument Co., Ltd, Mettler-Toledo International Inc., Wipotec-OCS GmbH, Bizerba GmbH & Co. KG and Sejong Pharmatech.
In July 2023, Thermo Fisher Scientific Inc ("Thermo Fisher"), the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC, a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies.
13.1 OCS Checkweighers GmbH
13.2 Thermo Fisher Scientific Inc.
13.3 Anritsu Corporation
13.4 Dover Corporation
13.5 Shanghai Bilon Instrument Co., Ltd
13.6 Mettler-Toledo International Inc.
13.7 Wipotec-OCS GmbH
13.8 Bizerba GmbH & Co. KG
13.9 Sejong Pharmatech